Featured Articles

• 

  Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when ...

  This editorial refers to Modes and timing of death in 66 252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials by D.D. Berg et al., on page 3810. ...

  By Wallentin, Lars Wednesday, November 7th 2018

• 

  Cardiovascular Round Table - Industry Partners

  The Cardiovascular Round Table comprises 20 industry partners from across the pharmaceuticals, devices and equipment sectors. Abbott Amgen AstraZeneca Bayer Boehringer-Ingelheim Bristol-Myers Squibb ...

  Wednesday, October 10th 2018

• 

  RE-CIRCUIT: uninterrupted anticoagulation with dabigatran to cover left atrial ablation procedures

  John Camm is Professor of Clinical Cardiology at St Georges University of London. His interests include cardiac arrhythmias, atrial fibrillation, stroke prevention, anticoagulation, clinical cardiac ...

  By Camm, A John Monday, October 1st 2018

• 

  Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. ...

  Abstract This Consensus Document is the first of two reports summarizing the views of an expert panel organized by the European Association of Percutaneous Cardiovascular Interventions (EAPCI) on ...

  By Räber, Lorenz Friday, September 14th 2018

• 

  Have you tried the all-new ESC 365?

  ESC Congress 365 is now ESC 365. This all-new platform includes resources from ESC Congress and ESC subspecialty congresses. It features an enhanced, easy-to-use search function so all these ...

  Tuesday, August 28th 2018

• 

  Initiating anticoagulation with the intention of cardioverting: does drug choice matter?

  Abstract This editorial refers to Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial by M.D. Ezekowitz et al., on ...

  By Mahaffey, Kenneth W Tuesday, August 21st 2018

• 

  Management of antithrombotic therapy in AF patients presenting with ACS and/or undergoing PCIA ...

  Since publication of the 2014 joint consensus document dealing with the management of antithrombotic therapy in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or ...

  By Lip, Gregory Y H Tuesday, August 14th 2018

• 

  Live from ESC Congress 2018

  Saturday 25 August Time Session 09:00 - 10:30 Expert Advice - Drug prescription in the elderly 10:30 - 11:00 Interlude 11:00 - 12:30 Expert Advice - Diagnosis and treatment of heart failure with ...

  Friday, July 27th 2018

• 

  Hugo A. Katus MD PhD FESCAfter discovering troponin as a biomarker Katus reached out to genome ...

  Known for his work developing a cardiac-specific troponin assay that revolutionized the diagnosis and management of myocardial injury, German cardiologist Hugo Katus has in recent years shifted his ...

  By Ozkan, Judy Saturday, July 14th 2018

• 

  Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of ...

  Abstract Aims Harmonized Assessment by Randomized Multicentre Study of OrbusNEichs Combo StEnt (HARMONEE) (NCT02073565) was a randomized pivotal registration trial of the Combo stent, which combined ...

  By Saito, Shigeru Saturday, July 7th 2018